Author

Na Liu

Shenyang Pharmaceutical UniversityORCID 0000-0001-5162-3791Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Na Liu9 papers · Hainan General Hospital

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Chutong TianiD· 1 shared Cong LuoiD· 1 shared Fenghui WangiD· 1 shared Ken‐ichiro KameiiD· 1 shared Qin YuiD· 1 shared Zeping Gao· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chutong TianORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCarbonPeer-reviewedFeb 7, 2025

Self-amplifying ROS-sensitive SN38 Dimeric Prodrug nanoparticles for Combined Chemotherapy and Ferroptosis in Cancer Treatment

Qin Yu, Na Liu, Fenghui Wang…·Ken‐ichiro Kamei

This paper develops SN38-CA@FC NPs, a ROS-sensitive dimeric prodrug nanoparticle that combines chemotherapy and ferroptosis to treat cancer, showing potent antitumor activity in cell lines and mouse models.

16 citations

mouseexperimental assay

𝕏 PostBluesky